DOI: 10.1055/s-00034922

Arthritis und Rheuma

LinksClose Window

References

Wei JC. et al.
Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial.

J Rheumatol 2003;
30 (12) 2627-2631.

Download Bibliographical Data

We do not assume any responsibility for the contents of the web pages of other providers.